LUMIVIB ARTEMETHER 80mg. IP + LUMEFANTRINE 480mg. IP

Lumivib tablets contain Artemether 80 mg + Lumefantrine 480 mg and are used for acute, uncomplicated malaria due to Plasmodium falciparum. Main uses: treatment of acute, uncomplicated malaria caused by Plasmodium falciparum; meant for infections in areas where resistance to chloroquine has been reported; to be used only at the age, weight and dose for which a doctor has prescribed this 80 mg/480 mg strength.

Common side effects of Lumivib Tablet include headache; loss of appetite; dizziness; weakness and tiredness; joint pain; muscle pain. Get medical help at once if you notice prolongation of the QT interval on the electrocardiogram (ECG); serious allergic or hypersensitivity reactions, including rash and swelling.

Each Lumivib tablet contains Artemether 80 mg + Lumefantrine 480 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Lumivib Tablet only as your doctor advises.

The MRP of Lumivib Tablet is ₹139.69 for a pack of 10x6 (Blister). For chemists and distributors, the PTR is ₹106.43 and the PTS is ₹95.79.

Each Lumivib tablet contains Artemether 80 mg + Lumefantrine 480 mg. It comes in a pack of 10x6 (Blister).

Artemether acts on the malaria parasite early and brings down the number of parasites in the blood. Lumefantrine then works over a longer period to clear the parasites that are left and to help stop the infection from coming back. Together they form a fixed-dose antimalarial combination in the ratio of 1:6.

Must not be used if you are allergic to artemether, lumefantrine or any ingredient of the tablet. Must not be used for severe or complicated Plasmodium falciparum malaria. Must not be used to prevent malaria. Must not be used with strong CYP3A4 inducers such as rifampin, carbamazepine, phenytoin or St. John's wort; halofantrine and these tablets should not be administered within one month of each other. Must not be used in patients with known QT prolongation (including congenital long QT syndrome), low potassium (hypokalemia) or low magnesium (hypomagnesemia) levels, or in those taking other medicines that prolong the QT interval.

Lumivib Tablet is a brand of Vibcare Pharma, sold through its Prima division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.